PharmVille
  • Home
  • Company Search
  • Search Jobs
  • Post Your Resume
  • Post A Job
  • Employers
  • Sign in
  • Sign up
  • Home
  • Company Search
  • Search Jobs
  • Post Your Resume
  • Post A Job
  • Employers

2 jobs found in Greenwich

Refine Search
Current Search
Greenwich Melville, NY
Search within
20 miles
10 miles 20 miles 50 miles 100 miles 200 miles
Refine by Categories
Pharmaceutical  (2) Science  (2) Business Development  (1) Consultant  (1) Customer Service  (1) General Business  (1)
Health Care  (1) Manufacturing  (1) Marketing  (1) Quality Control  (1) Sales  (1)
More
Refine by Job Type
Full time  (1)
LabCorp
Mar 17, 2026
Full time
Phlebotomist/Patient Service Technician PT (Greenwich PSC)
LabCorp Greenwich, CT, USA
A global life sciences and healthcare company seeking answers We believe in harnessing science for human good. And so we work day and night, around the world, to deliver answers for all your health questions—because we know that knowledge has the potential to make life better for all. WHAT WE DO We’re in the business of health answers. We tackle almost every known health challenge—from commonly understood and emerging viruses to life-threatening conditions and very rare diseases.  Our integrated approach means we’re able to see each idea through, full circle. Our work has helped to power clearer, more confident decisions for those dealing with some of life’s most critical choices. It’s why we promise to bring solutions to market with speed and precision—because every answer is paramount.
Amarin
Feb 27, 2026
Regional Account Manager
Amarin Greenwich, CT, USA
Amarin Corporation plc (“Amarin”) is a rapidly growing pharmaceutical company developing and selling therapeutics to improve cardiovascular health. Amarin, a publicly traded company (NASDAQ: AMRN) with approximately 900 employees, is headquartered in Dublin, Ireland and has its US operations (Amarin Pharma Inc.) based in Central New Jersey. Amarin has successfully developed, registered and launched VASCEPA® in the U.S. market with a network of third-party companies aligned with Amarin to advance commercialization of VASCEPA® globally. In the U.S., VASCEPA® was launched in 2013 for its initial indication of as a treatment of Very High Triglycerides (i.e. patients with TG levels ≥ 500mg/dL). In November 2018, unprecedented clinical results were announced from a landmark global cardiovascular outcomes study in which VASCEPA®demonstrated a significantly lower risk of cardiovascular events beyond the current standard of care for cholesterol management....
  • Home
  • Contact
  • About Us
  • Terms & Conditions
  • Employer
  • Post a Job
  • Search Resumes
  • Sign in
  • Job Seeker
  • Find Jobs
  • Resume Services
  • Post Your Resume
  • Facebook
  • LinkedIN
  • Twitter
© 2008-2026 Powered by PharmVille